+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Experimental Animal Model Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6153948
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Experimental Animal Model Market is projected to reach USD 1.31 Billion in 2026. It is expected to continue growing at a CAGR of 9.18%, reaching USD 2.23 Billion by 2032.

Experimental Animal Models: Executive Summary

Experimental animal models support biomedical research by enabling controlled investigation of disease mechanisms, therapeutic responses, toxicology, and translational biology. The field encompasses genetically defined, induced, spontaneous, surgical, and comparative models across species. Its development is shaped by scientific reproducibility, regulatory expectations, ethical oversight, data quality, and the growing need to connect preclinical findings with human biology.

Scientific Rigor and Welfare Are Reshaping Model Selection

The landscape is shifting toward better-validated models, stronger reporting standards, and more deliberate alignment between model choice and research question. Institutions are placing greater emphasis on the 3Rs-replacement, reduction, and refinement-alongside humane endpoints, enrichment, veterinary oversight, and transparent study protocols. Genetically engineered models, patient-derived systems, organoids, and computational approaches increasingly complement rather than universally replace in vivo studies, particularly where whole-organism physiology, immune interactions, or pharmacokinetics remain essential.

Artificial Intelligence Strengthens Design, Analysis, and Translation

Artificial intelligence is influencing experimental animal model workflows through automated image analysis, phenotype classification, behavioral monitoring, literature synthesis, and experimental design support. Machine-learning tools can help identify relevant disease signatures, improve longitudinal assessment, and reduce observer variability. Their value depends on representative training data, independent validation, explainability, cybersecurity, and careful control of bias. AI can support reduction and refinement, but it does not remove the need for biological expertise, ethical review, or confirmation of findings in appropriate systems.

Regional Insights: Regulation, Infrastructure, and Research Priorities Differ

North America combines advanced biomedical infrastructure with stringent institutional oversight and substantial activity in translational research. Europe places strong emphasis on animal-welfare governance, alternatives, harmonized standards, and reproducibility. Asia-Pacific is supported by expanding research capacity, manufacturing and pharmaceutical activity, and rising demand for specialized models. Latin America is developing capabilities unevenly, with opportunities linked to local disease research and laboratory modernization. The Middle East is investing selectively in research infrastructure and partnerships, while Africa’s needs center on capacity building, locally relevant models, veterinary expertise, and sustainable access to facilities and data.

Group Insights: Alliances and Economic Blocs Shape Collaboration

ASEAN countries are strengthening regional research connectivity while navigating varied regulatory and infrastructure conditions. BRICS members contribute diverse scientific capabilities and disease priorities, with collaboration shaped by national policy and access to specialized facilities. The European Union emphasizes common welfare principles, data standards, and cross-border research coordination. G7 economies generally have mature oversight systems and established translational networks. GCC states are expanding biomedical capacity through targeted investment and international collaboration. NATO members span highly developed research ecosystems and emphasize resilience, biosafety, and coordinated scientific capability, although practices remain governed by national and institutional rules.

Country Insights: Capabilities Reflect Distinct Scientific and Regulatory Contexts

The United States and Canada maintain broad biomedical research ecosystems with extensive institutional review and specialized model capabilities. The United Kingdom, Germany, France, Italy, and Spain operate within strong European welfare and research-governance frameworks, while each retains distinct national priorities. Japan and South Korea emphasize advanced biomedical engineering, genetics, and technology-enabled research. China is expanding research infrastructure and model development amid evolving standards and oversight. India is building capacity across pharmaceutical, academic, and translational settings. Australia combines strong research governance with expertise in comparative biology. Brazil and Mexico support important regional research programs, while Russia maintains established scientific institutions subject to national policy, resource, and collaboration conditions.

Priorities for Leaders: Improve Validity, Welfare, and Reproducibility

Industry and research leaders should begin with explicit translational objectives and select models against predefined biological, pharmacological, and clinical criteria. They should strengthen harmonized protocols, randomization, blinding, power calculations, endpoint definitions, and preregistration where appropriate. Investment in veterinary expertise, facility quality, workforce training, digital traceability, and interoperable data can improve reliability. Leaders should combine in vivo studies with validated human-relevant alternatives, use AI under strong governance, and create review processes that measure both scientific utility and welfare outcomes. Cross-border partnerships should address regulatory alignment, biosafety, material transfer, and data integrity from the outset.

Methodology: Structured Synthesis of Verified Market and Scientific Evidence

This executive summary uses a qualitative synthesis framework focused on the experimental animal model field. Analysis considers model types, research applications, welfare and regulatory principles, enabling technologies, translational requirements, and geographic research environments. Regional, group, and country observations are integrated from established scientific and policy patterns rather than speculative commercial claims. No market estimates, market shares, forecasts, or company-specific assessments are used. Because conditions vary by institution and jurisdiction, conclusions should be interpreted alongside current local regulations, ethical approvals, and validated primary research.

Conclusion: Translational Value Depends on Responsible Model Integration

Experimental animal models remain important where integrated physiology, disease progression, immune response, and safety questions cannot yet be addressed adequately by alternative systems alone. Their future depends less on volume of use than on scientific fit, reproducibility, humane practice, and credible translation to human outcomes. Organizations that combine rigorous design, responsible welfare governance, human-relevant alternatives, and carefully validated digital tools will be better positioned to generate dependable evidence across diverse research settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of CRISPR gene-editing technologies for precise animal model development and disease research
5.2. Rise of humanized mouse models for immuno-oncology research simulating human immune responses
5.3. Adoption of 3D bioprinting for generating organ-on-chip animal models to reduce animal usage
5.4. Growth in demand for non-rodent models such as zebrafish and nonhuman primates in toxicity testing
5.5. Expansion of in vivo imaging techniques such as PET and MRI for real-time monitoring in animal studies
5.6. Increasing focus on ethical standards driving adoption of alternative in vivo models and refined protocols
5.7. Partnerships between biotech companies and contract research organizations to accelerate custom animal model development
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Experimental Animal Model Market, by Animal Type
8.1. Introduction
8.2. Mouse
8.3. Non-Human Primate
8.4. Rabbit
8.5. Rat
8.6. Zebrafish
9. Experimental Animal Model Market, by Model Type
9.1. Introduction
9.2. Disease Induced
9.3. Knockout
9.4. Transgenic
9.4.1. Conditional
9.4.2. Knockin
9.4.3. Overexpression
9.4.4. Reporter
9.5. Xenograft
10. Experimental Animal Model Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Inflammation
10.4. Metabolism
10.5. Neurology
10.6. Oncology
10.6.1. Patient Derived Xenograft
10.6.2. Syngeneic
10.6.3. Xenograft
11. Experimental Animal Model Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Government And Non-Profit
11.5. Pharma And Biotech Companies
12. Experimental Animal Model Market, by Research Area
12.1. Introduction
12.2. Basic Research
12.3. Behavioral Studies
12.4. Drug Discovery
12.5. Genetic Research
12.6. Toxicology
13. Americas Experimental Animal Model Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Experimental Animal Model Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Experimental Animal Model Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Charles River Laboratories International, Inc.
16.3.2. Laboratory Corporation of America Holdings
16.3.3. Envigo RMS, Inc.
16.3.4. Taconic Biosciences, Inc.
16.3.5. The Jackson Laboratory
16.3.6. Inotiv, Inc.
16.3.7. Biomere, Inc.
16.3.8. BioIVT LLC
16.3.9. GenScript Biotech Corporation
16.3.10. Cyagen Biosciences (Suzhou) Co., Ltd.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. EXPERIMENTAL ANIMAL MODEL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EXPERIMENTAL ANIMAL MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EXPERIMENTAL ANIMAL MODEL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHAI
FIGURE 26. EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHSTATISTICS
FIGURE 27. EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHCONTACTS
FIGURE 28. EXPERIMENTAL ANIMAL MODEL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EXPERIMENTAL ANIMAL MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RABBIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RABBIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZEBRAFISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ZEBRAFISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE INDUCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DISEASE INDUCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY KNOCKOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY KNOCKOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONDITIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONDITIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY KNOCKIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY KNOCKIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY OVEREXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY OVEREXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REPORTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY REPORTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY INFLAMMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY METABOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY METABOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PATIENT DERIVED XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PATIENT DERIVED XENOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SYNGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY SYNGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GOVERNMENT AND NON-PROFIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GOVERNMENT AND NON-PROFIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY BEHAVIORAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY BEHAVIORAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 120. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 121. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 124. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 125. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 128. CANADA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 129. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 134. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 135. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 142. MEXICO EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 201. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 206. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 207. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 214. GERMANY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 215. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 220. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 221. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 228. FRANCE EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 243. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 244. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 245. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 248. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 249. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 256. ITALY EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 257. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 258. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 259. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 262. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 263. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 270. SPAIN EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY RESEARCH AREA, 2025-2030 (USD MILLION)
TABLE 313. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 314. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 315. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 317. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2018-2024 (USD MILLION)
TABLE 318. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY TRANSGENIC, 2025-2030 (USD MILLION)
TABLE 319. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 322. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 323. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. DENMARK EXPERIMENTAL ANIMAL MODEL MARKET SIZE, BY END USER, 2025-2030 (USD MILLI

Companies Mentioned

  • Altogen Labs, Inc.
  • Animal Biotech Industries Pvt. Ltd.
  • BioIVT LLC
  • Biomere, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Cyagen Biosciences (Suzhou) Co., Ltd.
  • Cyagen Biosciences Inc.
  • Envigo RMS, Inc.
  • GenOway S.A.
  • GenScript Biotech Corporation
  • Inotiv, Inc.
  • Inotiv, Inc.
  • Laboratory Corporation of America Holdings
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • Trans Genic, Inc.